Allspring Global Investments Holdings LLC Has $5.02 Million Holdings in Hawkins, Inc. $HWKN

Allspring Global Investments Holdings LLC increased its holdings in shares of Hawkins, Inc. (NASDAQ:HWKNFree Report) by 159.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 34,554 shares of the specialty chemicals company’s stock after buying an additional 21,216 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.17% of Hawkins worth $5,020,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in HWKN. Capital World Investors raised its stake in Hawkins by 618.8% during the 3rd quarter. Capital World Investors now owns 355,619 shares of the specialty chemicals company’s stock worth $64,979,000 after buying an additional 306,143 shares during the period. Invesco Ltd. raised its stake in shares of Hawkins by 44.4% in the 3rd quarter. Invesco Ltd. now owns 407,793 shares of the specialty chemicals company’s stock valued at $74,512,000 after purchasing an additional 125,444 shares during the period. Granite Investment Partners LLC acquired a new stake in shares of Hawkins in the 3rd quarter valued at about $11,610,000. Vanguard Group Inc. raised its stake in shares of Hawkins by 2.8% in the 3rd quarter. Vanguard Group Inc. now owns 1,504,831 shares of the specialty chemicals company’s stock valued at $274,963,000 after purchasing an additional 41,652 shares during the period. Finally, Wasatch Advisors LP raised its stake in shares of Hawkins by 10.9% in the 3rd quarter. Wasatch Advisors LP now owns 420,569 shares of the specialty chemicals company’s stock valued at $76,846,000 after purchasing an additional 41,184 shares during the period. Institutional investors and hedge funds own 69.71% of the company’s stock.

Insider Activity

In related news, Director James A. Faulconbridge bought 1,500 shares of the stock in a transaction that occurred on Wednesday, February 4th. The shares were acquired at an average price of $129.29 per share, with a total value of $193,935.00. Following the completion of the transaction, the director owned 50,907 shares in the company, valued at $6,581,766.03. The trade was a 3.04% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 4.10% of the company’s stock.

Hawkins Price Performance

NASDAQ:HWKN opened at $149.50 on Tuesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.46 and a current ratio of 2.35. The stock’s 50-day simple moving average is $144.81 and its 200 day simple moving average is $148.40. The company has a market cap of $3.12 billion, a P/E ratio of 37.85, a P/E/G ratio of 2.90 and a beta of 0.80. Hawkins, Inc. has a 52-week low of $101.72 and a 52-week high of $186.15.

Hawkins (NASDAQ:HWKNGet Free Report) last released its earnings results on Wednesday, January 28th. The specialty chemicals company reported $0.72 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.75 by ($0.03). The company had revenue of $244.08 million during the quarter, compared to analyst estimates of $252.51 million. Hawkins had a net margin of 7.75% and a return on equity of 16.85%. As a group, sell-side analysts forecast that Hawkins, Inc. will post 4 EPS for the current fiscal year.

Hawkins Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 27th. Investors of record on Friday, February 13th were given a $0.19 dividend. The ex-dividend date of this dividend was Friday, February 13th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.5%. Hawkins’s payout ratio is currently 19.24%.

Analysts Set New Price Targets

HWKN has been the topic of several recent research reports. Zacks Research raised Hawkins from a “strong sell” rating to a “hold” rating in a research note on Friday, January 2nd. Weiss Ratings downgraded Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, January 12th. Finally, BWS Financial reissued a “buy” rating and issued a $200.00 price target on shares of Hawkins in a research note on Monday, March 23rd. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $200.00.

Read Our Latest Research Report on HWKN

Hawkins Profile

(Free Report)

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.

Featured Articles

Institutional Ownership by Quarter for Hawkins (NASDAQ:HWKN)

Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.